These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3488021)

  • 21. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of altered PBPs and expression of cloned extended-spectrum beta-lactamases confers cefotaxime resistance in Haemophilus influenzae.
    Bozdogan B; Tristram S; Appelbaum PC
    J Antimicrob Chemother; 2006 Apr; 57(4):747-9. PubMed ID: 16492720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
    Perea EJ; Garcia Iglesias MC
    J Antimicrob Chemother; 1994 Jul; 34(1):161-4. PubMed ID: 7961203
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative activity of oral beta-lactam antibiotics against fifty strains of Haemophilus influenzae producing a beta-lactamase according to bacterial inoculum].
    Gaillot O; Simonet M
    Pathol Biol (Paris); 1994 May; 42(5):375-7. PubMed ID: 7824299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the activity of different macrolides on strains of Haemophilus influenzae].
    Ramírez de Arellano JA; Perea EJ
    Rev Esp Quimioter; 2000 Sep; 13(3):291-6. PubMed ID: 11086280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae.
    Jorgensen JH; Alexander GA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):342-3. PubMed ID: 306221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.
    Yu PK; Washington JA
    Antimicrob Agents Chemother; 1981 Jul; 20(1):63-5. PubMed ID: 6269484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO; Gezelius L
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countries.
    Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA; Bouchillon SK; Hoban DJ
    Eur J Clin Microbiol Infect Dis; 2001 Jan; 20(1):55-60. PubMed ID: 11245326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of extended-spectrum beta-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins.
    Tristram SG
    J Antimicrob Chemother; 2003 Jan; 51(1):39-43. PubMed ID: 12493785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
    Nash DR; Flanagan C; Steele LC; Wallace RJ
    Antimicrob Agents Chemother; 1991 Jan; 35(1):192-4. PubMed ID: 1901696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
    Bergeron MG; Claveau S; Simard P
    Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV; Vautour R
    Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial drug susceptibility of respiratory isolates of Hemophilus influenzae from adults.
    Saginur R; Bartlett JG
    Am Rev Respir Dis; 1980 Jul; 122(1):61-4. PubMed ID: 6967709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
    Renkonen OV
    Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom.
    Wise R; Andrews JM; Ashby JP; Thornber D
    Diagn Microbiol Infect Dis; 1991; 14(1):45-52. PubMed ID: 2013210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disc diffusion-based screening tests for extended-spectrum beta-lactamases in Haemophilus influenzae.
    Tristram SG; Bozdogan B; Appelbaum PC
    J Antimicrob Chemother; 2005 Apr; 55(4):570-3. PubMed ID: 15728142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action.
    Wise R; Andrews JM; Ashby JP; Thornber D
    J Antimicrob Chemother; 1990 Aug; 26(2):209-13. PubMed ID: 2120175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic susceptibility of invasive Haemophilus influenzae type b isolates in Denmark in 1988 and 1989.
    Kristensen K; Mortensen I
    Scand J Infect Dis; 1991; 23(3):337-40. PubMed ID: 1882199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.